SDSDownload

1-Amino-4-methylpiperazine / 25 G

Purity: 97 %
Synonym: 4-Methylpiperazin-1-amine; 4-Methyl-1-piperazinamine
Molecular Formula: C5H13N3
Molecular Weight: 115.18
SKU: MND-44325
CAS Number: 6928-85-4
MDL number: MFCD00006154
EC Number: 230-053-7
Form: liquid
Note: Prices are for comparison only. Contact Sales for current pricing.
Packing size: 25 G  
31.92 EUR



Safety Information


Hazard Statements

H315
H319
H335

Precautionary Statements

P280
P264
P305 + P351 + P338
P261
P271
P302 + P352

Pictograms



Properties

Signal WordWarning
Flash Point (C)63 °C - closed cup
Flash Point (F)145.4 °F - closed cup
Density0.957 g/mL at 25 °C (lit.)
Boiling Point172-175 °C (lit.)

 Product Description

1-AMINO-4-METHYLPIPERAZINE is a chemical compound commonly used as a building block in organic synthesis. It serves as a key intermediate in the production of pharmaceuticals, agrochemicals, and specialty chemicals.

 

Application:

1-AMINO-4-METHYLPIPERAZINE finds application primarily as a building block in organic synthesis. It is utilized in the synthesis of pharmaceuticals, agrochemicals, and specialty chemicals, enabling the creation of complex organic molecules.

 

 

Articles:

- Development and Validation of LC-MS/MS Method for the Determination of 1-Methyl-4-Nitrosopiperazine (MNP) in Multicomponent Products with Rifampicin—Analytical Challenges and Degradation Studies

Publication Date: 3 November 2023

Anna B. Witkowska, Aleksandra Wołczyńska, Agnieszka Lis-Cieplak and Elżbieta U. Stolarczyk

https://doi.org/10.3390/molecules28217405

 

- Characteristics of ignition delay of hypergolic ionic liquids combined with 1-amino-4-methylpiperazine

Publication Date: 22nd June 2023

Kyung Su Shin, Hoi-Gu Jang, Soon Hee Park and Sung June Cho

https://doi.org/10.1039/D3RA03752E

 

- A sensitive and accurate LC-MS/MS assay with the derivatization of 1-Amino-4-methylpiperazine applied to serum allopregnanolone, pregnenolone and androsterone in pre- and postmenopausal women

Publication Date: Available online 29 November 2016

Yuyong Ke, Renaud Gonthier, Fernand Labrie

https://doi.org/10.1016/j.steroids.2016.11.007